Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Vaccine|October 19, 2006
Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175Priyabrata Pattnaik, Ahmad Rushdi Shakri, Shailja Singh, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 3, 2006
Bacterially expressed and refolded envelope protein (domain III) of dengue virus type-4 binds heparan sulfatePriyabrata Pattnaik, J Pradeep Babu, Shailendra Kumar Verma, et al.Vaccine|July 22, 2008
Immunogenicity of a recombinant envelope domain III protein of dengue virus type-4 with various adjuvants in miceJ Pradeep Babu, Priyabrata Pattnaik, Nimesh Gupta, et al.Biotechnology Letters|June 24, 2006
Improvement in yield and purity of a recombinant malaria vaccine candidate based on the receptor-binding domain of Plasmodium vivax Duffy binding protein by codon optimizationSyed Shams Yazdani, Ahmad Rushdi Shakri, Priyabrata Pattnaik, et al.Protein and Peptide Letters|April 11, 2012
Expression, purification and evaluation of diagnostic potential and immunogenicity of dengue virus type 3 domain III proteinPradeep B J Reddy, Priyabrata Pattnaik, Nagesh K Tripathi, et al.Vaccines|June 27, 2025
An Open-Label, Randomized Field Trial Demonstrates Safety and Immunogenicity of Inactivated gE-Deleted Marker Vaccine Against Infectious Bovine Rhinotracheitis in CattleBhaskar Ganguly, Sarvesh Tayshete, Deepa Padinjare Melepat, et al.Biotechnology Advances|December 15, 2015
Clarification of vaccines: An overview of filter based technology trends and best practicesLise Besnard, Virginie Fabre, Michael Fettig, et al.Protein and Peptide Letters|December 17, 2009
Antibodies against refolded recombinant envelope protein (domain III) of Japanese encephalitis virus inhibit the JEV infection to Porcine Stable Kidney cellsShailendra Kumar Verma, Nimesh Gupta, Priyabrata Pattnaik, et al.Annals of Medicine and Surgery (2012)|June 8, 2026
Evidence-based One Health strategy is essential to eliminate rabies by 2030Krishna Prasad Acharya, Ranjan K Mohapatra, Snehasish Mishra, et al.Journal of Postgraduate Medicine|July 21, 2006
Fusogenic peptide as diagnostic marker for detection of flavivirusesPriyabrata Pattnaik, A Srivastava, A Abhyankar, et al.Pageof 3